Mylan

Mylan — Acquisitions

Every M&A deal made by Mylan, sorted by date.

Total deals 10 Total value $16.8B View company profile →
10
Total deals
$16.8B
Total value
$2.8B
Avg deal
$7.2B
Largest
Acquisition activity by year
Deals announced per year
98 04 06 07 10 11 13 16 19
# Acquired Date Type Status Price
1
The Upjohn Company
The Upjohn Company was a pharmaceutical manufacturing firm.
2019-07-29 Merge Complete $26.3M Deal →
2
Renaissance Acquisition Holdings
specialty and generics business.
2016-05-13 Acquisition Complete $950.0M Deal →
3
Meda
Meda AB is an international specialty pharmaceutical company, headquartered in S…
2016-02-10 Acquisition Complete $7.2B Deal →
4
A
Agila Specialties
Agila Specialties manufactures and markets pharmaceutical products.
2013-12-06 Acquisition Complete $1.8B Deal →
5
P
Pfizer - Respiratory Delivery Platform
Pfizer - Respiratory Delivery Platform comprises rights to develop, manufacture …
2011-11-09 Acquisition Complete Deal →
6
B
Bioniche Pharma Holdings Limited
Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceut…
2010-09-07 Acquisition Complete Deal →
7
M
Merck Generics
Merck Generics offers standard therapies in therapeutic areas through drugs cont…
2007-05-12 Acquisition Complete $6.7B Deal →
8
Matrix Laboratories
Matrix Laboratories Limited is a public limited company listed on BSE and NSE.
2006-08-28 Acquisition Complete Deal →
9
King Pharmaceuticals
King Pharmaceuticals develops, manufactures and markets therapies and technologi…
2004-07-26 Acquisition Complete Deal →
10
Penederm
Penederm is a healthcare company that markets topically administered prescriptio…
1998-06-29 Acquisition Complete $205.0M Deal →